HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BAC-EDTA transepithelial riboflavin-UVA crosslinking has greater biomechanical stiffening effect than standard epithelium-off in rabbit corneas.

Abstract
Studies suggest that standard corneal collagen crosslinking (CXL) is a safe and effective treatment to stiffen the cornea for keratoconus and other ectatic corneal disorders. The purpose of the present study was to compare the biomechanical effects of transepithelial benzalkonium chloride-EDTA (BAC-EDTA) riboflavin-UVA crosslinking to standard epithelium-off riboflavin-UVA crosslinking in a rabbit model. Corneal stiffness was quantified using optical coherence elastography at two months after treatment. The mean lateral-to-axial displacement ratio for the BAC-EDTA transepithelial CXL group was lower (greater stiffness) [0.062 ± 0.042, mean ± SD] than epithelium-off CXL (mean ± SD: 0.065 ± 0.045) or untreated control eyes (0.069 ± 0.044). Using ANOVA with Tukey correction, a statistically significant difference was found between the BAC-EDTA transepithelial CXL group and standard epithelium-off CXL (p = 0.0019) or the untreated control (p < 0.0001) groups. A graph of the probability density functions for biomechanical stiffness also showed a greater shift in stiffening in the BAC-EDTA transepithelial CXL group than the standard epithelium-off CXL or untreated control group. These results demonstrated that the biomechanical stiffening effect produced by BAC-EDTA transepithelial CXL was greater than that produced by standard epithelium-off CXL in a rabbit model.
AuthorsAndre A M Torricelli, Matthew R Ford, Vivek Singh, Marcony R Santhiago, William J Dupps Jr, Steven E Wilson
JournalExperimental eye research (Exp Eye Res) Vol. 125 Pg. 114-7 (Aug 2014) ISSN: 1096-0007 [Electronic] England
PMID24929203 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Benzalkonium Compounds
  • Chelating Agents
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Riboflavin
Topics
  • Analysis of Variance
  • Animals
  • Benzalkonium Compounds (pharmacology)
  • Biomechanical Phenomena (physiology)
  • Chelating Agents (pharmacology)
  • Cornea (drug effects, physiopathology)
  • Cross-Linking Reagents (pharmacology)
  • Elasticity (drug effects, physiology)
  • Elasticity Imaging Techniques
  • Models, Animal
  • Photosensitizing Agents (pharmacology)
  • Rabbits
  • Riboflavin (pharmacology)
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: